Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05853822 · ClinicalTrials.gov registry record
FirmTech User Research Trial
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 51
- Enrollment target
NCT05853822: Completed study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT05853822 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05853822 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The objective of this study is to see whether a home-use penile constriction device, Firmtech Tech Ring, can be determined to be superior to the Giddy device through evaluation of Leikert scale scores to assess ease of use and participant comfort and satisfaction with erectile quality with these devices. The primary outcome will be the satisfaction with use of the device as assessed through the Leikert scores. The other outcomes will be secondary.
Primary Outcome
A survey will be completed for each device after utilization
Interventions
- OTHER FirmTech Tech Ring
- OTHER Giddy Penile Constriction Ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2023-10-20 |
What the finished NCT05853822 record still lists
NCT05853822 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which FirmTech Tech Ring is the first listed.
NCT05853822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05853822 about?
NCT05853822 is a clinical study titled "FirmTech User Research Trial". The objective of this study is to see whether a home-use penile constriction device, Firmtech Tech Ring, can be determined to be superior to the Giddy device through evaluation of Leikert scale scores to assess ease of use and participant comfort and satisfaction with erectile quality with these dev...
What is the current status of trial NCT05853822?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2023-05-02. Estimated completion is 2023-10-20.
What interventions are being tested in trial NCT05853822?
The interventions under investigation include: FirmTech Tech Ring (OTHER), Giddy Penile Constriction Ring (OTHER).
Who is sponsoring clinical trial NCT05853822?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI